GO:1902416 positive regulation of mRNA binding: RNA Stability and Translation Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902416 (positive regulation of mRNA binding) describes any process that activates or increases the frequency, rate or extent of mRNA binding, as defined by QuickGO.
• It is a biological_process term that sits at the interface of RNA modification, RNA-binding protein (RBP) activity and post-transcriptional gene regulation.
• m5C RNA methylation can upregulate E2F1 expression in a YBX1 phase-separation-dependent manner, illustrating how RNA modifications feed into enhanced mRNA binding.
• Reduced structural rigidity of MDMX enhances its binding to TP53 mRNA, showing that protein conformational changes can positively regulate mRNA binding.
• The CCR4-NOT complex regulates early lymphocyte development through mRNA decay, demonstrating that mRNA-binding events are tightly coupled to immune cell fate.
• METTL3 modulates CDKN2B transcription and mRNA stability in colorectal cancer senescence, linking positive regulation of mRNA binding to tumor biology.
Description
Positive regulation of mRNA binding (GO:1902416) is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of mRNA binding. In practical terms, it captures the molecular events that make an mRNA molecule more likely to be recognized, held or stabilized by an RNA-binding protein or ribonucleoprotein complex. This term is central to post-transcriptional gene regulation because the fate of an mRNA, including its translation, localization and decay, depends on which proteins bind it and how stably they do so. Researchers studying this process are interested in how RNA modifications, RBP conformational changes and phase separation can all converge to enhance mRNA binding. The importance of GO:1902416 extends across development, immunity and cancer. For example, m5C modification can upregulate E2F1 expression in a manner dependent on YBX1 phase separation, directly linking an RNA modification to enhanced mRNA binding and tumor progression in ovarian cancer. In parallel, reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA, showing that a single protein conformational change can positively regulate mRNA binding. The CCR4-NOT complex regulates early lymphocyte development via mRNA decay, illustrating that mRNA-binding events are not merely housekeeping but shape immune cell differentiation. Because positive regulation of mRNA binding is mechanistically diverse, it is studied with a wide range of tools, including RNA immunoprecipitation, crosslinking and immunoprecipitation, RNA-seq, Ribo-seq and imaging of mRNA transport. This article summarizes the QuickGO definition, the major molecular players, disease connections and the CRISPR-based models that can be used to dissect this process.
positive regulation of mRNA binding At A Glance
| GO ID | GO:1902416 |
|---|---|
| GO term | positive regulation of mRNA binding |
| Ontology | biological_process |
| Synonym | activation of mRNA binding; up regulation of mRNA binding; up-regulation of mRNA binding; upregulation of mRNA binding |
| Major function | Increases the frequency, rate or extent of mRNA binding by RNA-binding proteins and ribonucleoprotein complexes |
| Definition source | QuickGO definition: Any process that activates or increases the frequency, rate or extent of mRNA binding |
| Biological context | Post-transcriptional gene regulation, including mRNA stability, transport, translation and decay |
| Representative mechanisms | RNA modification-dependent recruitment (e.g. m5C/YBX1), conformational change of RNA-binding proteins, phase separation |
| Disease relevance | Cancer progression, cellular senescence, lymphocyte development and neurological RNA transport |
What Is GO:1902416?
According to QuickGO, GO:1902416 (positive regulation of mRNA binding) is a biological_process defined as any process that activates or increases the frequency, rate or extent of mRNA binding. In other words, it is the positive arm of the regulation of mRNA binding: it does not describe the binding event itself, but the upstream or concurrent processes that make mRNA binding more frequent, faster or more extensive. Synonyms include activation of mRNA binding, up regulation of mRNA binding, up-regulation of mRNA binding and upregulation of mRNA binding.
Why Is positive regulation of mRNA binding Important in Cell Biology?
Positive regulation of mRNA binding is important because it determines how efficiently an mRNA is engaged by the RNA-binding machinery that controls its stability, localization and translation. When this process is enhanced, an mRNA can be stabilized or translated more actively, as seen when m5C modification upregulates E2F1 expression in a YBX1 phase-separation-dependent manner and promotes tumor progression in ovarian cancer. Conversely, when mRNA binding is dysregulated, processes such as lymphocyte development and cellular senescence can be affected. Understanding GO:1902416 therefore provides a mechanistic handle on post-transcriptional control in health and disease.
• Controls mRNA stability and translation efficiency by enhancing RBP-mRNA engagement.
• Links RNA modifications such as m5C to downstream gene expression changes.
• Can be driven by conformational changes in RNA-binding proteins, as shown for MDMX binding to TP53 mRNA.
• Shapes immune cell development through mRNA decay complexes such as CCR4-NOT.
• Contributes to cancer phenotypes, including ovarian cancer progression and colorectal cancer senescence.
• Is relevant to neurological processes because mRNA transport and translation in axons depend on regulated mRNA binding.
• Provides a mechanistic entry point for therapeutic targeting of post-transcriptional networks.
• Can be studied with CRISPR knockout, point mutation, knock-in and overexpression models to test causality.
• Small RNAs and Hfq can positively regulate mRNA binding in bacterial systems, showing evolutionary conservation of the concept.
• Serves as a bridge between RNA modification writers/erasers and downstream RNA-binding effectors.
What Happens During positive regulation of mRNA binding?
RNA modification creates a binding platform
In simple terms: Chemical marks on mRNA can act like landing pads that help proteins bind more easily.
RNA modifications can positively regulate mRNA binding by creating or enhancing recognition sites for RNA-binding proteins. In ovarian cancer, m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation, directly linking an RNA modification to enhanced mRNA binding and tumor progression. This illustrates a general principle: modification writers can increase the frequency or extent of mRNA binding by specific reader proteins.
Conformational change of the RNA-binding protein
In simple terms: If a protein changes shape, it can grab its mRNA target more tightly.
Positive regulation of mRNA binding can also arise from changes in the RNA-binding protein itself. Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA, demonstrating that a conformational change in the protein can increase mRNA binding. This mechanism shows that the regulation can be protein-centric rather than RNA-centric, and that structural flexibility is a determinant of binding strength.
Phase separation and condensate formation
In simple terms: Proteins and RNAs can cluster into droplets that concentrate binding partners.
Phase separation is an emerging mechanism that can positively regulate mRNA binding by concentrating RNA-binding proteins and their targets. YBX1 phase separation is required for m5C-dependent upregulation of E2F1 expression, indicating that condensate formation can enhance mRNA binding and downstream expression. This subsection connects GO:1902416 to the broader biology of biomolecular condensates.
mRNA decay complexes and stability control
In simple terms: Binding can either protect an mRNA or mark it for destruction, depending on the complex.
The CCR4-NOT complex regulates early lymphocyte development via mRNA decay, showing that mRNA-binding events are integrated with decay machinery. In colorectal cancer, METTL3 promotes cellular senescence via modulation of CDKN2B transcription and mRNA stability, further linking mRNA-binding regulation to stability control. Together, these examples show that positive regulation of mRNA binding can be coupled to either stabilization or decay depending on the molecular context.
Transport and local translation
In simple terms: In neurons, mRNAs must be carried to the right place and translated there.
Regulation of mRNA transport and translation in axons depends on mRNA-binding events that determine where and when an mRNA is translated. Positive regulation of mRNA binding in this context can increase the efficiency of local translation, which is critical for neuronal function. This subsection highlights the spatial dimension of GO:1902416.
Small RNA and Hfq-dependent positive regulation
In simple terms: In bacteria, small RNAs can help a protein called Hfq bind mRNA better.
Positive regulation by small RNAs and the role of Hfq demonstrate that mRNA binding can be enhanced by small regulatory RNAs in bacteria. This provides an evolutionary perspective on GO:1902416 and shows that the principle of positive regulation of mRNA binding is not limited to eukaryotes.
Key Genes Involved in GO:1902416 positive regulation of mRNA binding
The following genes and proteins are representative players connected to positive regulation of mRNA binding, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| YBX1 | m5C reader that undergoes phase separation to upregulate E2F1 expression | Ovarian cancer progression and RNA modification-dependent mRNA binding |
| E2F1 | Transcription factor whose mRNA is upregulated by m5C/YBX1-dependent mRNA binding | Tumor progression and cell cycle control |
| MDMX | RNA-binding protein whose reduced structural rigidity enhances TP53 mRNA binding | TP53 pathway regulation and protein-RNA structural biology |
| TP53 | Tumor suppressor whose mRNA is bound by MDMX | Cancer biology and mRNA binding regulation |
| CCR4-NOT complex | mRNA decay machinery regulating early lymphocyte development | Immune cell differentiation and mRNA decay |
| METTL3 | m6A writer modulating CDKN2B transcription and mRNA stability | Colorectal cancer senescence and mRNA stability |
| CDKN2B | Cell cycle inhibitor whose mRNA stability is modulated by METTL3 | Cellular senescence and cancer |
| HNRNPH1 | RNA-binding protein regulating RBM3 expression through poison exon exclusion | Neuroprotective cold-shock protein regulation |
| RBM3 | Cold-shock protein with neuroprotective functions | Neuronal protection and mRNA processing |
| SIRT7 | Regulator of brown adipose tissue energy expenditure and thermogenesis | Metabolic regulation and RNA-related pathways |
| Hfq | Bacterial RNA chaperone involved in small RNA-mediated positive regulation | Bacterial mRNA binding and small RNA biology |
| Small RNAs | Positive regulators of mRNA binding in bacteria | Evolutionary conservation of mRNA binding regulation |
| Axonal mRNA transport machinery | Regulates mRNA transport and translation in axons | Neuronal local translation |
| m5C modification machinery | Writes m5C marks that enhance mRNA binding | RNA modification-dependent gene regulation |
| m6A modification machinery | Writes m6A marks affecting mRNA stability | Cancer and senescence biology |
| Poison exon splicing regulators | Control inclusion/exclusion of poison exons in RBM3 | Neuroprotective gene expression |
How Is positive regulation of mRNA binding Regulated?
Positive regulation of mRNA binding is itself regulated at multiple levels. RNA modifications such as m5C can enhance the binding of reader proteins like YBX1, which in turn upregulates target mRNAs such as E2F1. Protein conformational changes, as shown for MDMX binding to TP53 mRNA, can increase binding affinity without changing mRNA abundance. mRNA decay complexes such as CCR4-NOT regulate the stability of transcripts during lymphocyte development, showing that the decay machinery is a regulatory node for mRNA binding. METTL3-dependent modulation of CDKN2B transcription and mRNA stability further illustrates how writers and erasers of RNA modifications can tune mRNA binding and stability. In neurons, the transport and translation machinery regulates where mRNA binding occurs, adding a spatial layer of control. Finally, small RNAs and Hfq can positively regulate mRNA binding in bacteria, indicating that this regulation is evolutionarily ancient.
positive regulation of mRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YBX1 | Ovarian cancer progression | Knockout and overexpression in ovarian cancer cell lines |
| METTL3 | Colorectal cancer senescence | Knockout and point mutation in colorectal cancer cells |
| CCR4-NOT complex | Early lymphocyte development | Knockout in immune cell models |
| MDMX | TP53 pathway dysregulation | Point mutation to alter structural rigidity |
| HNRNPH1 | Neuroprotection via RBM3 | Knockout and knock-in of splicing regulatory elements |
Ovarian cancer and RNA modification-dependent mRNA binding
In ovarian cancer, m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression. This directly connects positive regulation of mRNA binding to oncogenic gene expression and suggests that targeting this axis could be therapeutically relevant.
Colorectal cancer and cellular senescence
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability. Because mRNA stability is downstream of mRNA binding, this study links GO:1902416 to senescence and colorectal cancer biology.
Lymphocyte development and immune regulation
Regulation of early lymphocyte development via mRNA decay catalyzed by the CCR4-NOT complex demonstrates that mRNA-binding and decay events are essential for immune cell differentiation. Dysregulation of this process could contribute to immune disorders.
Neurological function and axonal mRNA transport
Regulation of mRNA transport and translation in axons is critical for neuronal function, and disruptions in mRNA binding can affect local translation. HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 through poison exon exclusion, further linking mRNA processing and binding to neuroprotection.
From positive regulation of mRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of YBX1 reduce m5C-dependent E2F1 mRNA binding? | YBX1 knockout cell line |
| Does a rigidity-altering mutation in MDMX change TP53 mRNA binding? | MDMX point mutation knock-in |
| Does CCR4-NOT disruption alter lymphocyte development? | Knockout of CCR4-NOT subunits in immune cells |
| Does METTL3 overexpression stabilize CDKN2B mRNA? | METTL3 overexpression and knockout |
| Does HNRNPH1 regulate RBM3 poison exon exclusion? | HNRNPH1 knockout and tagged knock-in |
| Can phase separation of YBX1 be visualized? | Tagged knock-in of YBX1 with fluorescent tag |
How to Study the positive regulation of mRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | Physical binding of proteins to mRNA | Testing YBX1 or MDMX binding to target mRNAs |
| CLIP | Crosslinked protein-RNA interactions | Mapping binding sites on mRNAs |
| RNA-seq | mRNA abundance changes | Measuring downstream effects of mRNA binding |
| mRNA stability assay | mRNA half-life | Testing METTL3-dependent CDKN2B stability |
| Fluorescence imaging | Localization of mRNA and condensates | Visualizing YBX1 phase separation and axonal mRNA transport |
| CRISPR knockout | Loss-of-function effects | Testing causality of candidate genes |
| CRISPR point mutation | Effect of specific amino acid changes | Testing MDMX structural rigidity |
| CRISPR knock-in | Tagged or mutant allele expression | Visualizing endogenous proteins |
RNA immunoprecipitation and CLIP-based methods
RNA immunoprecipitation (RIP) and crosslinking and immunoprecipitation (CLIP) can measure the physical binding of proteins such as YBX1 or MDMX to target mRNAs like E2F1 or TP53. These methods are central to testing whether a candidate gene positively regulates mRNA binding.
RNA-seq and stability measurements
RNA-seq can quantify changes in mRNA abundance, while stability assays can determine whether mRNA half-life is altered, as shown for METTL3-dependent CDKN2B mRNA stability. These approaches link mRNA binding to downstream expression changes.
Imaging of mRNA transport and phase separation
Imaging approaches can visualize mRNA transport in axons and phase-separated condensates involving YBX1. These methods provide spatial information that complements biochemical binding assays.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes implicated in positive regulation of mRNA binding. For example, knockout of YBX1 or METTL3 can reveal whether a specific mRNA-binding event depends on these factors.
How CRISPR Can Be Used to Study GO:1902416 positive regulation of mRNA binding
Knockout
CRISPR knockout of genes such as YBX1, METTL3 or CCR4-NOT subunits can test whether they are required for positive regulation of mRNA binding. Loss-of-function models are essential for establishing causality in this process.
Point Mutation
Point mutation models can be used to alter specific residues that affect RNA-binding protein conformation, as illustrated by the reduced structural rigidity of MDMX that enhances TP53 mRNA binding. Such models allow precise structure-function studies of mRNA binding regulation.
Knock-in
Knock-in of tagged alleles, such as fluorescently tagged YBX1 or HNRNPH1, enables visualization of endogenous protein localization and condensate formation. This is particularly useful for studying phase separation and mRNA transport.
Overexpression
Overexpression of writers such as METTL3 or readers such as YBX1 can enhance mRNA binding and downstream expression, providing gain-of-function evidence for positive regulation of mRNA binding. Overexpression models complement knockout studies.
How EDITGENE Supports positive regulation of mRNA binding Research
Researchers studying positive regulation of mRNA binding-related genes often need to determine whether a candidate gene is causally involved in enhancing mRNA binding, or whether it is merely correlated with the phenotype. This requires precise genetic models that can knock out, mutate, tag or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mRNA binding research.
Frequently Asked Questions About positive regulation of mRNA binding
What is GO:1902416 positive regulation of mRNA binding?
GO:1902416 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of mRNA binding.
What genes are involved in positive regulation of mRNA binding?
Genes such as YBX1, E2F1, MDMX, TP53, METTL3, CDKN2B, HNRNPH1 and RBM3 have been implicated in processes related to mRNA binding and stability.
How does m5C modification regulate mRNA binding?
m5C modification can upregulate E2F1 expression in a manner dependent on YBX1 phase separation, linking RNA modification to enhanced mRNA binding.
What is the role of YBX1 in mRNA binding?
YBX1 acts as an m5C reader whose phase separation is required for upregulation of E2F1 expression in ovarian cancer.
How does MDMX bind TP53 mRNA?
Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA, showing that conformational changes can positively regulate mRNA binding.
What is the role of CCR4-NOT in mRNA binding?
The CCR4-NOT complex regulates early lymphocyte development via mRNA decay, demonstrating that mRNA-binding events are coupled to immune cell differentiation.
How does METTL3 affect mRNA stability?
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.
How is mRNA transport regulated in neurons?
Regulation of mRNA transport and translation in axons depends on mRNA-binding events that determine where and when an mRNA is translated.
Can small RNAs positively regulate mRNA binding?
Yes, positive regulation by small RNAs and the role of Hfq demonstrate that mRNA binding can be enhanced by small regulatory RNAs in bacteria.
What research methods are used to study positive regulation of mRNA binding?
Methods include RNA immunoprecipitation, CLIP, RNA-seq, mRNA stability assays, imaging and CRISPR-based genetic perturbation.
Conclusion
GO:1902416 (positive regulation of mRNA binding) captures a fundamental layer of post-transcriptional control in which RNA modifications, protein conformational changes and phase separation converge to enhance the engagement of mRNAs by RNA-binding proteins. Its relevance spans cancer, immune development, senescence and neuronal function, making it a rich area for mechanistic and translational research. CRISPR-based knockout, point mutation, knock-in and overexpression models, combined with RNA-centric methods, provide the tools needed to dissect this process and identify therapeutic targets.
References
- 1. Liu X et al.. 2024. RNA m(5)C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer.. Exp Mol Med 56(3):600-615 PMID: 38424195
- 2. Kucerikova M et al.. 2025. Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA.. Biosci Rep 45(11):683-96 PMID: 41230869
- 3. Akiyama T et al.. 2021. Regulation of Early Lymphocyte Development via mRNA Decay Catalyzed by the CCR4-NOT Complex.. Front Immunol 12:715675 PMID: 34349771
- 4. Chen Z et al.. 2024. METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.. Oncogene 43(13):976-991 PMID: 38361047
- 5. Lin JQ et al.. 2023. HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.. EMBO J 42(14):e113168 PMID: 37248947
- 6. Yoshizawa T et al.. 2022. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice.. Nat Commun 13(1):7439 PMID: 36509749
- 7. Vuppalanchi D et al.. 2009. Regulation of mRNA transport and translation in axons.. Results Probl Cell Differ 48:193-224 PMID: 19582411
- 8. Soper T et al.. 2010. Positive regulation by small RNAs and the role of Hfq.. Proc Natl Acad Sci U S A 107(21):9602-7 PMID: 20457943
